Clinical Trials Logo

Clinical Trial Summary

The primary purpose of the study is to evaluate safety and tolerability of a single application of Ha44 Gel 0.74% w/w for the treatment of head lice. Secondary purpose is to evaluate PK of Ha44 and benzyl alcohol under conditions of maximal exposure in pediatric population.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02010333
Study type Interventional
Source Dr. Reddy's Laboratories Limited
Contact
Status Completed
Phase Phase 2
Start date April 2013
Completion date August 2014

See also
  Status Clinical Trial Phase
Completed NCT02097485 - Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation Phase 2
Recruiting NCT04878276 - Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once
Completed NCT01907490 - Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation Phase 2
Completed NCT02060903 - A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation Phase 3
Completed NCT02062060 - Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation Phase 3
Recruiting NCT06057506 - Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation N/A